Sarah Cannon Outcomes Registry

首次发布于 2015 年 2 月 5 日

SARAH Exercise Program in Patients With Rheumatoid Arthritis

计划入组 49 人 · 首次发布于 2023 年 2 月 14 日

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

计划入组 200 人 · 首次发布于 2025 年 2 月 27 日

Mesendo (TCA Cellular Therapy)

Mesendo(TCA Cellular Therapy, LLC)

novel cellular therapy (lung injury)

Avera Mckennan

United States

Sarah Cannon Research Institute, LLC

United States

Sarah Khan

Germany

St. David's South Austin Medical Center Enrolls First Patient Globally in Phase III CAR T-Cell Trial for Aggressive Large B-Cell Lymphoma

Exa-cel Gene Therapy Demonstrates Durable Benefits in Sickle Cell Disease, Preventing VOCs

BostonGene and Sarah Cannon Research Institute Partner to Enhance Precision Oncology